OKAIROS AG has a total of 25 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are BEIJING FIVEPLUS MOLECULAR MEDICINE INST CO LTD, HOLM PER SONNE and ALPHAVAX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | New Zealand | 2 | |
#8 | Singapore | 2 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | Mexico | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nicosia Alfredo | 23 |
#2 | Cortese Riccardo | 22 |
#3 | Colloca Stefano | 10 |
#4 | Ammendola Virginia | 9 |
#5 | Ambrosio Maria | 9 |
#6 | Vitelli Alessandra | 8 |
#7 | Alfredo Nicosia | 2 |
#8 | Riccardo Cortese | 2 |
#9 | Virginia Ammendola | 1 |
#10 | Folgori Antonella | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014005643A1 | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides | |
WO2012089231A1 | Paramyxovirus vaccines | |
AU2010209938A1 | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
CA2726914A1 | A vaccine for the prevention and therapy of hcv infections | |
WO2010085984A1 | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |